Quick View
| Metric | Current Period | Prior Year Period | YoY |
|---|---|---|---|
| Revenue / Net Sales | ¥1309.2B | ¥1371.2B | -4.5% |
| Operating Income / Operating Profit | ¥48.8B | ¥79.2B | -38.4% |
| Ordinary Income | ¥49.2B | ¥81.8B | -39.9% |
| Net Income | ¥15.4B | ¥46.8B | -67.0% |
| ROE | 1.4% | 3.9% | - |
Executive Summary
For the fiscal year ended March 2026, Revenue was ¥1,309.2B (YoY ▲¥62.0B ▲4.5%), Operating Income was ¥48.8B (YoY ▲¥30.4B ▲38.4%), Ordinary Income was ¥49.2B (YoY ▲¥32.6B ▲39.9%), and Net income attributable to owners of parent was ¥5.1B (YoY ▲¥41.7B ▲89.1%), resulting in lower revenue and profits. Operating margin was 3.7%, deteriorating by ▲2.0pt YoY, and gross margin fell to 30.5%, down ▲1.0pt YoY. Net income declined sharply due to recording special losses of ¥45.3B, including ¥33.1B of restructuring expenses, and the effective tax rate rose to 48.9%. The Apparel Business swung to an operating loss of ¥13.3B, while the Functional Solutions Business maintained solid performance with Operating Income of ¥72.3B (+0.4%), which supported corporate earnings.
Drivers of Performance
[Revenue] Revenue was ¥1,309.2B, a decrease of ▲4.5% YoY. By geography, Japan was ¥1,033.9B (prior year ¥1,090.5B) and Overseas was ¥275.3B (prior year ¥280.7B), both down. By segment, the Functional Solutions Business had the largest revenue at ¥475.4B (YoY ▲8.9%) but declined from the prior year; the Apparel Business also fell to ¥586.0B (YoY ▲3.6%). Meanwhile, the Medical Business ¥132.0B (YoY +1.9%) and Life Create Business ¥125.3B (YoY +4.4%) grew, but their smaller scale could not offset the company-wide revenue decline. Gross margin was 30.5%, down ▲1.0pt YoY, suggesting worse product mix and discounting pressure.
[Profit & Loss] Gross profit was ¥398.8B (gross margin 30.5%), SG&A was ¥349.9B (SG&A ratio 26.7%), resulting in Operating Income of ¥48.8B (operating margin 3.7%). SG&A ratio was roughly flat YoY, but lower gross margin caused operating margin to deteriorate by ▲2.0pt. Non-operating income was ¥9.5B (dividend income received ¥1.6B, foreign exchange gains ¥0.2B, etc.), and non-operating expense was ¥9.1B (interest expense ¥0.8B, foreign exchange losses ¥0.3B, etc.), yielding Ordinary Income of ¥49.2B (YoY ▲39.9%). Special gains were ¥7.5B (gain on sale of fixed assets ¥3.1B, etc.), while special losses totaled ¥45.3B (restructuring expenses ¥33.1B, impairment losses ¥4.6B, loss on disposal of fixed assets ¥3.5B, etc.), compressing Profit before tax to ¥11.4B. After deducting income taxes of ¥5.6B (effective tax rate 48.9%) and non-controlling interests of ¥0.8B, Net income attributable to owners of parent was ¥5.1B (net margin 0.4%), a substantial decrease of ▲89.1% YoY. One-off restructuring costs and high tax burden materially reduced bottom-line earnings. In conclusion, the company experienced both revenue and profit decline, driven by weaker core earnings and one-time charges.
Segment Analysis
The Functional Solutions Business (Revenue ¥475.4B, YoY ▲8.9%) generated Operating Income of ¥72.3B (YoY +0.4%), a margin of 15.2%, and is the core business contributing approximately 148% of consolidated Operating Income. The Medical Business (Revenue ¥132.0B, YoY +1.9%) recorded Operating Income of ¥14.7B (YoY ▲39.3%), margin 11.2%; despite revenue growth, cost increases drove profit decline. The Apparel Business (Revenue ¥586.0B, YoY ▲3.6%) swung to an operating loss of ¥13.3B (prior year operating income ¥3.7B, YoY ▲277.2%), with a margin of ▲2.3%, indicating severe underperformance. Slower inventory turnover, discounting pressure, and weakened product competitiveness are likely causes of the loss. The Life Create Business (Revenue ¥125.3B, YoY +4.4%) delivered Operating Income of ¥12.3B (YoY +24.7%), margin 9.8%, sustaining revenue and profit growth. Consolidated Operating Income of ¥48.8B was driven by Functional Solutions and Life Create, partially offsetting the Apparel deficit.
Key Financial Metrics
[Profitability] ROE was 1.4% (prior year 3.9%), a steep decline primarily due to deterioration in net margin to 0.4% (prior year 3.4%). Operating margin was 3.7% (prior year 5.8%) and gross margin was 30.5% (prior year 31.5%), indicating weaker profitability; high-margin Functional Solutions (margin 15.2%) was diluted by Apparel’s loss (▲2.3%). [Cash Quality] Operating Cash Flow (OCF) was ¥172.7B, 33.9x Net income ¥5.1B, supported by depreciation of ¥72.6B, inventory decrease ¥53.6B, and receivables decrease ¥24.7B — non-cash items and working capital improvements contributed. OCF/EBITDA was 1.42x indicating healthy cash conversion, though the low Net income inflates this ratio. [Investment Efficiency] Capex of ¥125.5B was 1.73x depreciation ¥72.6B, evidencing active growth investment. Total asset turnover was 0.85x (prior year 0.86x), nearly flat, indicating stable asset efficiency. [Financial Soundness] Equity Ratio was 74.0% (prior year 75.6%), Current Ratio 250.6%, Quick Ratio 181.5%, showing very strong liquidity. Interest-bearing debt was ¥61.4B, Debt/EBITDA 0.51x, and interest coverage 62.6x, indicating high debt tolerance. Cash and deposits were ¥99.4B versus short-term borrowings of ¥8.8B, implying very low liquidity risk.
Cash Flow Analysis
OCF was ¥172.7B (YoY +49.2%), increased significantly by adding back before-tax profit ¥11.4B, depreciation ¥72.6B, restructuring expenses ¥33.1B and other non-cash items; working capital contributed via inventory decrease ¥53.6B and receivables decrease ¥24.7B, partially offset by a decrease in trade payables ¥9.3B. Payments for income taxes were ¥7.2B, receipts of interest and dividends ¥2.7B, and interest payments ¥0.7B, resulting in an OCF subtotal of ¥191.1B. Investing Cash Flow was ▲¥115.8B, driven by acquisition of tangible and intangible fixed assets ▲¥121.5B, offset by proceeds from sales ¥6.7B, sale of investment securities ¥13.9B and purchases ¥▲13.6B, reflecting aggressive Capex. Financing Cash Flow was ▲¥63.2B, with dividend payments ▲¥63.1B and share buybacks ▲¥50.1B offset partly by long-term borrowings raised ¥53.0B and repayments ▲¥26.1B, with short-term borrowings increases partially supplementing. Free Cash Flow was positive ¥56.9B (OCF ¥172.7B − Investing CF ¥115.8B) but internal cash generation fell short of total shareholder returns of about ¥113.4B, so some was funded from existing cash and the balance sheet. Working capital efficiency: Days Sales Outstanding (DSO) 63 days, Days Inventory Outstanding (DIO) 77 days, Days Payable Outstanding (DPO) 28 days, giving CCC of 112 days (worsening YoY); although inventory was reduced, the cash conversion cycle remains long.
Quality of Earnings
The divergence between Ordinary Income ¥49.2B and Profit before tax ¥11.4B (▲77%) is mainly due to one-off factors: special losses of ¥45.3B (including restructuring expenses ¥33.1B, impairment losses ¥4.6B, loss on disposal of fixed assets ¥3.5B). Non-operating items were almost neutral, with non-operating income ¥9.5B (dividend income ¥1.6B, FX gains ¥0.2B, etc.) and non-operating expenses ¥9.1B (interest expense ¥0.8B, FX losses ¥0.3B, etc.) offsetting each other. Special gains ¥7.5B (gain on sale of fixed assets ¥3.1B, etc.) were also recorded, but the scale of special losses significantly depressed final profit. OCF ¥172.7B vs Net income ¥5.1B yields OCF/Net income ratio of 33.9x, extremely high because Net income was compressed by one-time losses; accruals are ▲10.9% ((OCF − Net income)/Total assets) and sit on the healthy side. Recurring earnings power is shown by Operating Income ¥48.8B and Ordinary Income ¥49.2B; excluding one-off items, earnings quality appears stable. The effective tax rate of 48.9% is high, suggesting valuation adjustments to deferred tax assets and increased tax burden from group reorganization, indicating room for normalization. Comprehensive income was ¥43.4B, exceeding consolidated Net income ¥15.4B, aided by OCI gains such as ¥2.1B foreign currency translation adjustments and ¥29.5B actuarial gains related to retirement benefit plans; the gap with Net income is mainly due to pension asset valuation gains, which do not directly translate into cash generation.
Forecasts & Guidance
The company plan for the fiscal year ending March 2027 projects Revenue ¥1,320.0B (YoY +0.8%), Operating Income ¥88.0B (YoY +80.3%), Ordinary Income ¥84.0B (YoY +70.7%), and Net income attributable to owners of parent ¥52.0B. The implied operating margin is 6.7%, an improvement of +3.0pt vs this year and above the prior-year level (5.8%). The large recovery in Operating Income is expected to reflect a reversal of the ¥33.1B restructuring expenses recorded this year, narrowing of the Apparel loss, and stable performance in Functional Solutions. The forecast assumes a modest revenue increase (+0.8%) but a substantial +80% operating profit improvement, implying benefits from fixed-cost absorption and cost-structure reforms; achieving this will require gross margin recovery and a turnaround in Apparel. The dividend forecast is annual ¥0, but this is stated on a post-stock-split basis (1 share → 2 shares effective April 1, 2025), and the substantive dividend policy will be disclosed separately.
Shareholder Returns
An interim/final dividend totaling ¥216 per share at year-end (ordinary dividend ¥147 + special dividend ¥69) was paid, amounting to ¥63.31B. The payout ratio relative to Net income attributable to owners of parent ¥5.09B was about 1,244%, extremely high; dividend funding came from retained earnings and internal reserves. Additionally, share buybacks of ¥50.1B were executed, bringing total shareholder returns to approximately ¥113.4B. Coverage of total returns by Free Cash Flow ¥56.9B was 0.50x, meaning returns far exceeded internally generated cash and were partly financed by cash on the balance sheet and long-term borrowings (¥53.0B raised). The dividend policy appears to rely heavily on special dividends; the forecast for FY2027 shows a dividend forecast of ¥0 (post-split basis), so the sustainability of dividends requires separate assessment. Even limiting to the ordinary dividend ¥147 would amount to about ¥46.5B annually, which exceeds this year’s Net income substantially; assuming forecast Net income ¥52.0B next year, sustainability improves, but continuation of special dividends depends on earnings and FCF.
Risk Factors
-
Risk of continued Apparel losses: The Apparel Business swung to an operating loss of ¥13.3B, with DIO of 77 days and prolonged inventory turnover, discounting pressure, and weakening product competitiveness becoming apparent. This year’s inventory reduction of ¥53.6B shows efforts to compress inventory, but revenue decline and gross margin ▲1.0pt indicate weak demand and markdown losses. Going forward, consumption trends and intensified EC competition could widen the deficit or delay a return to profitability.
-
Risk from deteriorating working capital efficiency: CCC at 112 days is worsening YoY, with DSO 63 days and DIO 77 days indicating a long cash collection cycle. Although inventory compression progressed, during revenue downturns receivables and inventory stagnation can re-emerge and hinder sustainable OCF generation. Seasonal fluctuation and obsolescence risk in Apparel inventory remain concerns that could pressure gross margin and increase markdowns.
-
Risk of delayed realization of restructuring effects: The company recorded ¥33.1B of restructuring expenses, and the FY2027 plan (+80% Operating Income) assumes visible benefits from reforms; however, execution delays or insufficient cost reductions could make achieving a 6.7% operating margin difficult. The pace of Apparel loss reduction, progress in fixed-cost cuts, and Functional Solutions’ ability to pass through prices are key, and adverse external conditions raise downside risk to the plan.
Industry Benchmark (Reference, Company Data)
Profitability & Returns
| Metric | Company | Median (IQR) | Delta |
|---|---|---|---|
| Operating Margin | 3.7% | 4.6% (1.7%–8.2%) | -0.9pt |
| Net Margin | 1.2% | 3.3% (0.9%–5.8%) | -2.2pt |
Profitability lags the industry median, with Apparel losses and one-off expenses depressing margins.
Growth & Capital Efficiency
| Metric | Company | Median (IQR) | Delta |
|---|---|---|---|
| Revenue Growth Rate (YoY) | -4.5% | 4.3% (2.2%–13.0%) | -8.8pt |
Revenue growth is well below the industry median, impacted by declines in core Apparel and Functional Solutions segments.
※Source: Company compilation
Key Points from the Financial Results
-
Contribution of Functional Solutions and progress of restructuring: With Operating Income ¥72.3B and margin 15.2%, the Functional Solutions Business’s strength in contributing about 148% of consolidated operating profit is a key strength and central to achieving the company’s plan of +80% Operating Income next year. Realization of the benefit from the ¥33.1B restructuring charge recorded this year and visible fixed-cost reductions are essential to reach an operating margin of 6.7%; quarterly progress and the pace of Apparel loss reduction should be monitored.
-
Scope to improve working capital efficiency and sustainability of inventory compression: Inventory was reduced by ¥53.6B and OCF was strong at ¥172.7B, but CCC of 112 days indicates the cash recovery cycle remains long; during sales recovery, receivables and inventory could re-expand. Shortening DIO from 77 days and maintaining/improving DSO 63 days are keys to improving ROIC and sustaining FCF; gross margin recovery (reduced markdowns) and SG&A flexibility directly impact profitability improvement.
-
Sustainability of shareholder returns and financial flexibility: Total returns of ¥63.3B in dividends + ¥50.1B buybacks = ¥113.4B far exceed FCF ¥56.9B and were supplemented by retained cash and long-term borrowings. Assuming next year’s Net income forecast ¥52.0B, dividend sustainability improves, but continuation of special dividends is uncertain and contingent on earnings and FCF. With an Equity Ratio of 74.0% and interest-bearing debt ¥61.4B, financial capacity is solid, enabling simultaneous growth investment and returns, but maintaining current high levels of returns requires recovery in operating margin and FCF generation.
This report is an AI-generated earnings analysis based on XBRL financial statement data. It does not constitute a recommendation to invest in any particular security. Industry benchmarks are reference information compiled by the company from public financial statements. Investment decisions are your responsibility; consult a professional advisor as necessary.